Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: TARS) | Delayed: 72.53 +2.03 (2.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $70.50 | 52 Week High | $ | |||
| Open | $70.93 | 52 Week Low | $ | |||
| Day High | $72.88 | P/E | N/A | |||
| Day Low | $69.55 | EPS | $ | |||
| Volume | 298,654 | |||||
